| Literature DB >> 27695326 |
Jayanta Kumar Patra1, Kwang-Hyun Baek2.
Abstract
The aim of this study was to compare the biological synthesis of gold nanoparticles (Entities:
Keywords: Cucumis melo; Prunus persica; antibacterial; anticandidal; antioxidant; gold nanoparticles; proteasome inhibitor
Mesh:
Substances:
Year: 2016 PMID: 27695326 PMCID: PMC5028107 DOI: 10.2147/IJN.S108920
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1Fruit peels of oriental melon (Cucumis melo) (A) and peach (Prunus persica) (B) used for the synthesis of AuNPs.
Abbreviation: AuNPs, gold nanoparticles.
Figure 2UV–visible spectroscopy and change in color of the reaction mixture at different time intervals of the synthesized OMP-AuNPs and PE-AuNPs.
Notes: (A) OMP-AuNPs; (B) PE-AuNPs.
Abbreviations: AuNPs, gold nanoparticles; OMP, oriental melon peel; PE, peach extract; UV, ultraviolet.
Figure 3SEM image of synthesized OMP-AuNPs and PE-AuNPs.
Notes: (A) OMP-AuNPs; (B) PE-AuNPs.
Abbreviations: AuNPs, gold nanoparticles; OMP, oriental melon peel; PE, peach extract; SEM, scanning electron microscopy.
Figure 4EDX analysis of synthesized OMP-AuNPs and PE-AuNPs.
Notes: OMP-AuNPs (A–C) and PE-AuNPs (D–F).
Abbreviations: AuNPs, gold nanoparticles; EDX, energy dispersive X-ray; OMP, oriental melon peel; PE, peach extract.
Figure 5XRD spectra of synthesized OMP-AuNPs and PE-AuNPs.
Notes: (A) OMP-AuNPs; (B) PE-AuNPs.
Abbreviations: AuNPs, gold nanoparticles; OMP, oriental melon peel; PE, peach extract; XRD, X-ray powder diffraction.
Figure 6FT-IR analysis of synthesized OMP-AuNPs and PE-AuNPs.
Notes: (A) OMP-AuNPs; (B) PE-AuNPs.
Abbreviations: AuNPs, gold nanoparticles; FT-IR, Fourier transform infrared spectroscopy; OMP, oriental melon peel; PE, peach extract.
Figure 7TG/DTG analysis of synthesized OMP-AuNPs and PE-AuNPs.
Notes: (A) OMP-AuNPs; (B) PE-AuNPs.
Abbreviations: AuNPs, gold nanoparticles; Deriv., derivative; DTG, derivative thermogravimetric; OMP, oriental melon peel; PE, peach extract; TG, thermogravimetric.
Comparative synergistic antibacterial activity of OMP-AuNPs (25 μg) and PE-AuNPs (25 μg) with standard antibiotics, kanamycin (5 μg) or rifampicin (5 μg), against foodborne pathogenic bacteria
| Bacteria | Antibacterial activity (control samples)
| Synergistic antibacterial activity
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AuNPs with kanamycin
| AuNPs with rifampicin
| ||||||||||
| OMP extract | PE | OMP-AuNPs | PE-AuNPs | Kanamycin | Rifampicin | DMSO | OMP-AuNPs + kanamycin | PE-AuNPs + kanamycin | OMP-AuNPs + rifampicin | PE-AuNPs + rifampicin | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.42±0.74c, | 10.47±0.50c,d | 10.04±0.19c | 9.52±0.14d | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.03±0.52c | 20.45±0.51a | 9.78±0.38c,d | 10.01±0.21c,d | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.38±0.27d | 13.48±0.56b | 0.00±0.00e | 0.00±0.00e | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.26±0.90b | 13.98±0.07b | 22.39±0.53b | 25.23±0.90a | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.23±0.28c | 13.07±0.21b | 0.00±0.00e | 0.00±0.00e | |
Notes:
Data are expressed as the mean zone of inhibition in millimeter ± SD. Values with different superscript letters in the columns with kanamycin and in the columns of AuNPs with rifampicin are significantly different at P<0.05.
Abbreviations: AuNPs, gold nanoparticles; ATCC, American Type Culture Collection; B. cereus, Bacillus cereus; DMSO, dimethyl sulphoxide; E. coli, Escherichia coli; L. monocytogenes, Listeria monocytogenes; OMP, oriental melon peel; PE, peach extract; S. typhimurium, Salmonella typhimurium; S. aureus, Staphylococcus aureus.
Comparative synergistic anticandidal activities of OMP-AuNPs (50 μg) and PE-AuNPs (50 μg) mixed with amphotericin B (5 μg), a standard antifungal agent against pathogenic Candida species
| Anticandidal activity (control samples)
| Synergistic anticandidal activity
| |||||||
|---|---|---|---|---|---|---|---|---|
| OMP extract | PE | Amphotericin B | DMSO | OMP-AuNPs | PE-AuNPs | OMP-AuNPs + amphotericin B | PE-AuNPs + amphotericin B | |
| 0 | 0 | 0 | 0 | 0 | 0 | 10.96±0.93e, | 10.97±0.41d,e | |
| 0 | 0 | 0 | 0 | 0 | 0 | 14.45±0.53b | 15.47±0.27a | |
| 0 | 0 | 0 | 0 | 0 | 0 | 10.66±0.47d,e | 11.09±0.66d | |
| 0 | 0 | 0 | 0 | 0 | 0 | 13.27±0.28c | 14.25±0.22b | |
| 0 | 0 | 0 | 0 | 0 | 0 | 10.09±0.30e | 11.08±0.28d,e | |
Notes:
Data are expressed as the mean zone of inhibition in millimeter ± SD. Values with different superscript letters are significantly different at P<0.05.
Abbreviations: AuNPs, gold nanoparticles; DMSO, dimethyl sulphoxide; OMP, oriental melon peel; PE, peach extract; SD, standard deviation.
Figure 8Antioxidant potential of synthesized OMP-AuNPs and PE-AuNPs.
Notes: (A) DPPH free radical scavenging potential; (B) nitric oxide scavenging potential; (C) ABTS radical scavenging potential; and (D) reducing power potential. Values with different superscript letters are significantly different at P<0.05.
Abbreviations: ABTS, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); AuNPs, gold nanoparticles; BHT, butylated hydroxyl toluene; DPPH, 1,1-diphenyl-2-picrylhydraxyl; OMP, oriental melon peel; PE, peach extract.
Figure 9Proteasome inhibitory potential of both OMP-AuNPs and PE-AuNPs and standard reference compound, Epox.
Notes: 100 μg/mL (OMP-AuNP_100, PE-AuNP_100); 10 μg/mL (OMP-AuNP_10, PE-AuNP_10); 1 μg/mL (OMP-AuNP_1, PE-AuNP_1) and 5.56 μg/mL (Epox_10); 2.78 μg/mL (Epox_5) and 0.56 μg/mL (Epox_1).
Abbreviations: AuNPs, gold nanoparticles; FU, fluorescence units; Epox, epoxomicin; OMP, oriental melon peel; PE, peach extract.